, Mustafa Duran, MD 1 , and Sani Namik Murat, MD 1 Oikonomou et al 1 report an association between alcohol consumption and ascending thoracic aorta dilatation in their valuable study. We aim to contribute to their article by presenting "renin-angiotensin-aldosterone system (RAAS)" as another possible underlying mechanism to explain this association. Renin-angiotensin-aldosterone system is a hormonal cascade that functions in the homeostatic control of arterial pressure, tissue perfusion, and extracellular volume. Dysregulation of the RAAS is responsible in the pathogenesis of various cardiovascular disorders. 2 Several animal studies [3] [4] [5] [6] indicated that RAAS plays an important role in the development of both abdominal and thoracic aortic aneurysms (AAs), by different pathways. Daugherty and Cassis 4 investigated the effect of chronic angiotensin II (Ang II) infusion on the severity of the atherogenic process in low-density lipoprotein (LDL) receptor À/À mice with established lesions. They reported that chronic infusion of Ang II promoted the atherogenic processes in LDL receptor À/À mice with an increase at cholesterol content in lesions of the arch, thoracic, and abdominal aorta at doses which did not markedly elevate systolic pressure. Wang et al 5 showed that Ang II infusion resulted in an elevation of urokinase-type plasminogen activator (uPA) expression, which increased in human abdominal aortic aneurysm (AAA), contributing to aneurysm formation. They concluded that Ang II infusion resulted in macrophage infiltration, increased uPA activity, and aneurysm formation in the abdominal aorta of mice. Eagleton et al 6 reported that Ang II induced an early increase in aortic matrix metalloproteinase (MMP) expression and MMP activity, which led to aneurysm formation, by triggering elastin fragmentation on arterial wall, in mice. Ayabe et al 7 confirmed these findings. They showed that Ang II caused prompt aneurysm formation in hyperlipidemic mice independently from change of blood pressure (BP). Liao et al 8 reported that treatment with angiotensin converting enzyme (ACE) inhibitors suppressed the development of elastase-induced AAA in the rat. Administration of a direct renin inhibitor, aliskiren prevented the expansion of experimental AA by reduction in Ang I and II production, independent of its BP-lowering effect, in a rabbit model. 9 Liu et al 10 described a novel AA animal model induced by mineralocorticoid receptor agonist and high salt, and revealed potentially significant role of aldosterone in the pathogenesis of AA. The mineralocorticoid receptor antagonists significantly attenuated salt-induced AA. Human studies 11, 12 also demonstrated the association between RAAS and AA. In a metaanalysis, 11 ACE I/D polymorphism was a risk factor for AA. Furthermore, Lee et al 12 reported that the addition of RAAS blockade to b-blocker treatment decreased aortic dilatation and clinical events in patients with Marfan syndrome.
Previous studies [13] [14] [15] demonstrated that alcohol consumption affected RAAS activity. Jing et al 13 reported that myocardial Ang I, Ang II, and renin levels were progressively increased at 2, 4, and 6 months of alcohol intake, in a rat model. Husain et al 14 found that chronic ethanol intake elevated tissue Ang II levels, activation of nicotinamide adenine dinucleotide phosphate oxidase activity, and depletion of endothelial nitric oxide causing endothelial injury and impaired vascular relaxation in rats (these effects may facilitate AA formation). In a human study, plasma renin activity increased in patients consuming heavy alcohol consumption compared with mild or moderate alcohol consumption. 15 Okuno et al 16 reported increased ACE serum activity in hospitalized chronic alcoholics compared to healthy controls. Cheng et al 17 investigated the effect of Ang II type 1 receptor (AT1) blockade on the development of alcoholic cardiomyopathy in a dog study. They evaluated left ventricular (LV) and cardiomyocyte function and the RAS over 6 months in 3 groups consisted of only alcohol intake (once per day orally), alcohol intake and irbesartan (AT1 blockade agent) therapy, and controls. Compared with controls, alcohol consumption caused sustained RAS activation with progressive increases in plasma levels of Ang II, renin activity, LV ACE activity, and LV myocyte Ang II AT1 expression. With alcohol plus irbesartan, plasma Ang II, cardiac ACE activity, and AT1 remained close to control values.
Consequently, according to the findings above, it may be suggested that activated RAAS is one of underlying mechanism to explain the effect of alcohol consumption on AA in the Oikonomou et al study. 1 In this article 1 , as shown in Tables 3  and 4 , elevated BP was not an independent factor in the study population. It is well-known that alcohol consumption affects RAAS activity. [13] [14] [15] As in this study, activated RAAS can lead to some of changes including fatty accumulation, macrophage infiltration, increased uPA activity, increased MMP activity, and triggering elastin fragmentation on arterial wall independently of change on BP. [4] [5] [6] [7] [8] In a recent study, de Lima et al 18 showed once again that Ang II, even at doses that do not alter BP, induces the expression of inflammatory markers and migration of inflammatory cells into the aorta of normotensive mice. Further studies can clarify the mechanisms proposed here by measuring markers of RAAS activity including plasma renin levels, ACE activity, and Ang II. 
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